Logo

454 Licenses Sequencing Techniques from Pyrosequencing

Aug 19, 2003

NEW YORK, Aug. 19 (GenomeWeb News) - CuraGen subsidiary 454 Life Sciences has exclusively licensed sequencing by synthesis and pyrophosphate-based sequencing techniques from Pyrosequencing of Uppsala, Sweden, the companies said today.

 

Under the agreement, 454 of Branford, Conn., will pay Pyrosequencing at least $4.5 million.

After the fifth year, 454 has an option to maintain the exclusivity of the license at a cost of $500,000 to $1 million per year.

 

The license provides 454 with the exclusive worldwide rights for five years to use the technology in whole genome analysis - and in making instruments and kits that use the technology - while Pyrosequencing will retain rights for other applications.

 

 

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.